Overactive Inflammasome in Artery Muscle Cells Drives Dangerous Vessel Thickening in Mice

When a cardiologist threads a stent into a clogged coronary artery or a surgeon grafts a vein around a blocked vessel, the procedure itself sets off a healing response that can undo the benefit. The arterial wall thickens, a process called intimal hyperplasia, and the renewed tissue can gradually choke off blood flow once again. This restenosis problem, along with the growth of atherosclerotic plaques, remains one of the most stubborn challenges in cardiovascular medicine. Now a team of researchers at the University of Houston and Virginia Commonwealth University has produced some of the clearest evidence yet that a single inflammatory sensor inside vascular smooth muscle cells can act as a powerful engine driving this pathological thickening. Their study, published in the Journal of Molecular Medicine, points to the NLRP3 inflammasome as a potential therapeutic target for keeping treated arteries open.

NLRP3, short for NOD-like receptor pyrin domain 3, is a pattern-recognition protein that assembles into a multi-protein machine known as an inflammasome. When the sensor detects danger signals, ranging from cholesterol crystals to products of cellular damage, it triggers the enzyme caspase-1, which in turn processes the inflammatory messengers interleukin-1 beta and interleukin-18. Caspase-1 also cleaves Gasdermin D, producing an N-terminal fragment that punches pores in the cell membrane and initiates a fiery form of cell death called pyroptosis. Inflammasome hyperactivation is already infamous in human medicine: inherited gain-of-function mutations in NLRP3 cause cryopyrin-associated periodic syndromes, devastating autoinflammatory diseases. What has been missing is direct in vivo evidence showing what happens when this same sensor is chronically overactive specifically within the smooth muscle cells of the artery wall.

To answer that question, the team, led by Yun-Ting Wang, Xiang Li, and Yang Zhang, engineered a mouse carrying an Nlrp3 gain-of-function mutation, the L351P variant, exclusively in vascular smooth muscle cells by combining the knock-in allele with a Myh11-driven Cre recombinase. This model, dubbed Nlrp3-SMKI, allowed the investigators to isolate the contribution of smooth muscle-intrinsic inflammasome signaling from the contributions of immune cells and endothelium. The researchers then subjected these animals and control mice to partial ligation of the carotid artery under hypercholesterolemic conditions, a well-established surgical model that produces disturbed blood flow, endothelial dysfunction, and rapid development of neointimal lesions that mimic human restenosis and early atherosclerosis.

The results were striking even before any surgical injury was applied. In unligated arteries of the mutant mice, the team already detected elevated caspase-1 activation-associated signaling, indicating that the hyperactive inflammasome was quietly simmering within the vessel wall under baseline conditions. When the carotid artery was partially ligated, this inflammatory activity surged further, revealing that the gain-of-function mutation primed the smooth muscle cells to mount an exaggerated response to vascular stress. In other words, the mutation did not merely add inflammation after injury; it fundamentally lowered the threshold at which the arterial wall responded to danger.

Downstream of caspase-1, the pathological cascade unfolded across multiple fronts. The ligated arteries of the mutant mice showed heightened vascular inflammation, marked by increased expression of VCAM1, an adhesion molecule that recruits inflammatory cells, and by greater accumulation of macrophage-associated signals within the vessel wall. The researchers also documented enhanced Gasdermin D and Gasdermin D N-terminal-associated signaling, the molecular signature of pyroptotic cell injury, together with increased numbers of TUNEL-positive cells indicating cell death. These findings weave smooth muscle cells into the inflammatory fabric of the lesion in a way that earlier cell-culture studies had suggested but could not prove in a living organism.

The functional consequence was a dramatically worsened structural outcome. Neointimal lesion growth was significantly exacerbated in the mutant animals, as measured by increased intimal area and an elevated intima-to-media ratio, the standard metrics of pathological vessel thickening. Because the only genetic difference between the experimental and control groups was the hyperactive Nlrp3 allele confined to smooth muscle cells, the study provides compelling causal evidence that smooth muscle-intrinsic inflammasome signaling is not a passive bystander in intimal hyperplasia but an active driver of lesion expansion.

Perhaps the most clinically provocative finding concerned lipid metabolism. The injured arteries of the mutant mice accumulated more lipid and displayed foam cell-like remodeling, including within regions containing alpha-smooth muscle actin-positive cells. Foam cells, the cholesterol-engorged cells that define atherosclerotic plaques, have traditionally been associated with macrophages, but a growing body of literature shows that vascular smooth muscle cells can undergo phenotypic switching and adopt foam cell characteristics, becoming a major and underappreciated cellular component of plaques. The new data indicate that NLRP3 hyperactivation within smooth muscle cells actively promotes this lipid-laden transformation in the injured arterial wall, linking inflammasome signaling directly to one of the hallmarks of atherosclerosis.

Beneath these observations, the researchers uncovered a possible mechanistic explanation involving cellular housekeeping. The mutant arteries showed reduced expression of transcription factor EB, or TFEB, the master regulator of lysosomal biogenesis and autophagy, along with altered expression of lysosome- and autophagy-related markers. TFEB orchestrates the cell’s waste-disposal and recycling systems, and previous work by some of the same investigators showed that activating TFEB ameliorates smooth muscle dedifferentiation and neointima formation in mice fed a high-fat diet. The new findings suggest that NLRP3 hyperactivation may disrupt these stress-adaptive pathways, leaving smooth muscle cells less able to digest damaged proteins, clear lipids, and maintain their contractile identity during vascular remodeling. The association between inflammasome overactivity and impaired lysosomal-autophagic function offers an attractive framework for understanding how inflammation and metabolic dysfunction reinforce each other in the diseased artery.

The clinical implications are considerable. Cardiovascular disease remains the leading cause of death worldwide, and while statins and the anti-inflammatory antibody canakinumab have demonstrated that taming inflammation reduces cardiovascular events, broadly suppressing the immune system carries risks. The new study suggests that a more precise strategy, targeting NLRP3-associated signaling specifically within vascular smooth muscle cells, could limit restenosis after stenting or bypass grafting and slow plaque progression without wholesale immunosuppression. Several NLRP3 inhibitors are already in development for other inflammatory conditions, and the mouse model created by the Houston and Richmond team provides a platform for testing whether such compounds can keep injured arteries open. As with all murine studies, translation to human patients will require careful validation, and the authors note that their data establish associations alongside causal effects that warrant further mechanistic dissection. Still, by pinpointing a single molecular sensor in a single cell type as a linchpin of arterial thickening, the work transforms our understanding of what happens inside a vessel wall after injury, and it offers a concrete molecular bullseye for the next generation of cardiovascular anti-inflammatory therapies.

Subject of Research: The role of vascular smooth muscle NLRP3 inflammasome hyperactivation in arterial intimal hyperplasia and restenosis

Article Title: Vascular smooth muscle-specific NLRP3 hyperactivation exacerbates arterial intimal hyperplasia in mice

Article References: Wang, Y.-T., Moura, A. K., Zuo, R., Gao, W., McConnell, B. K., Li, G., Li, P.-L., Li, X., & Zhang, Y. (2026). Vascular smooth muscle-specific NLRP3 hyperactivation exacerbates arterial intimal hyperplasia in mice. Journal of Molecular Medicine, 104(1), Article 116. https://doi.org/10.1007/s00109-026-02724-3

Image Credits: AI Generated

DOI: 10.1007/s00109-026-02724-3

Keywords: NLRP3, inflammasome, vascular smooth muscle cells, intimal hyperplasia, restenosis, caspase-1, Gasdermin D, pyroptosis, TFEB, lysosome-autophagy, foam cells, atherosclerosis